Alzheimer’s Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
The global alzheimer’s drugs market size reached US$ 7.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 10.4 Billion by 2028, exhibiting a growth rate (CAGR) of 6.11% during 2023-2028.
Alzheimer's is a disease characterized by the degeneration of nerve cells in several areas of the brain. It causes loss of cognitive function, such as memory, language, thinking and behavior. The common symptoms of Alzheimer's include depression, memory impairment, loss of inhibitions, and problems with thinking and reasoning. It is usually diagnosed by performing physical exams, blood tests, brain imaging, and mental status and neuropsychological testing. According to the results, doctors prescribe different medications to alleviate symptoms. Alzheimer’s drugs influence the functions of neurotransmitters, the chemicals involved in carrying messages between nerve cells in the brain.
Alzheimer’s Drugs Market Trends:
Diabetes, obesity, heart diseases and high blood pressure (BP), in confluence with sedentary lifestyles, unhealthy dietary patterns and smoking, are some of the factors known to increase the chances of developing Alzheimer's disease. An increase in the prevalence of these ailments and lifestyle choices among the masses, coupled with the rising geriatric population, represents one of the key factors driving the market growth. Furthermore, the leading pharmaceutical companies are focusing on the development of drugs that prevent the disease and provide long-lasting improvements in cognitive functions. The market growth is further supported by the expansion of telehealth services and the growing traction of online pharmacies. These platforms have enabled disease diagnosis and drug delivery in remote regions. Apart from this, various Alzheimer's drugs are presently under late-stage clinical trials, including Aducanumab, Solanezumab and Insulin.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global alzheimer’s drugs market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on drug class and distribution channel.
Breakup by Drug Class:
Donepezil
Galantamine
Rivastigmine
Memantine
Others
Breakup by Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Online Stores
Others
Breakup by Region:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Abbvie Inc., AstraZeneca PLC, Biogen Inc., Daiichi Sankyo Company Limited, Daiichi Sankyo Company Limited, Eisai Co. Ltd., Eli Lilly and Company, H. Lundbeck A/S, F. Hoffmann-La Roche AG, Merck & Co. Inc., Novartis AG, Ono Pharmaceutical Co. Ltd., Pfizer Inc and Teva Pharmaceutical Industries Limited.
Key Questions Answered in This Report:
How has the global alzheimer’s drugs market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global alzheimer’s drugs market?
What are the key regional markets?
What is the breakup of the market based on the drug class?
What is the breakup of the market based on the distribution channel?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global alzheimer’s drugs market and who are the key players?
What is the degree of competition in the industry?
Alzheimer's is a disease characterized by the degeneration of nerve cells in several areas of the brain. It causes loss of cognitive function, such as memory, language, thinking and behavior. The common symptoms of Alzheimer's include depression, memory impairment, loss of inhibitions, and problems with thinking and reasoning. It is usually diagnosed by performing physical exams, blood tests, brain imaging, and mental status and neuropsychological testing. According to the results, doctors prescribe different medications to alleviate symptoms. Alzheimer’s drugs influence the functions of neurotransmitters, the chemicals involved in carrying messages between nerve cells in the brain.
Alzheimer’s Drugs Market Trends:
Diabetes, obesity, heart diseases and high blood pressure (BP), in confluence with sedentary lifestyles, unhealthy dietary patterns and smoking, are some of the factors known to increase the chances of developing Alzheimer's disease. An increase in the prevalence of these ailments and lifestyle choices among the masses, coupled with the rising geriatric population, represents one of the key factors driving the market growth. Furthermore, the leading pharmaceutical companies are focusing on the development of drugs that prevent the disease and provide long-lasting improvements in cognitive functions. The market growth is further supported by the expansion of telehealth services and the growing traction of online pharmacies. These platforms have enabled disease diagnosis and drug delivery in remote regions. Apart from this, various Alzheimer's drugs are presently under late-stage clinical trials, including Aducanumab, Solanezumab and Insulin.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global alzheimer’s drugs market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on drug class and distribution channel.
Breakup by Drug Class:
Donepezil
Galantamine
Rivastigmine
Memantine
Others
Breakup by Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
Online Stores
Others
Breakup by Region:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Abbvie Inc., AstraZeneca PLC, Biogen Inc., Daiichi Sankyo Company Limited, Daiichi Sankyo Company Limited, Eisai Co. Ltd., Eli Lilly and Company, H. Lundbeck A/S, F. Hoffmann-La Roche AG, Merck & Co. Inc., Novartis AG, Ono Pharmaceutical Co. Ltd., Pfizer Inc and Teva Pharmaceutical Industries Limited.
Key Questions Answered in This Report:
How has the global alzheimer’s drugs market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global alzheimer’s drugs market?
What are the key regional markets?
What is the breakup of the market based on the drug class?
What is the breakup of the market based on the distribution channel?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global alzheimer’s drugs market and who are the key players?
What is the degree of competition in the industry?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL ALZHEIMER’S DRUGS MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY DRUG CLASS
6.1 Donepezil
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Galantamine
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Rivastigmine
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Memantine
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Others
6.5.1 Market Trends
6.5.2 Market Forecast
7 MARKET BREAKUP BY DISTRIBUTION CHANNEL
7.1 Hospital Pharmacy
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Retail Pharmacy
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Online Stores
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast
8 MARKET BREAKUP BY REGION
8.1 North America
8.1.1 United States
8.1.1.1 Market Trends
8.1.1.2 Market Forecast
8.1.2 Canada
8.1.2.1 Market Trends
8.1.2.2 Market Forecast
8.2 Asia Pacific
8.2.1 China
8.2.1.1 Market Trends
8.2.1.2 Market Forecast
8.2.2 Japan
8.2.2.1 Market Trends
8.2.2.2 Market Forecast
8.2.3 India
8.2.3.1 Market Trends
8.2.3.2 Market Forecast
8.2.4 South Korea
8.2.4.1 Market Trends
8.2.4.2 Market Forecast
8.2.5 Australia
8.2.5.1 Market Trends
8.2.5.2 Market Forecast
8.2.6 Indonesia
8.2.6.1 Market Trends
8.2.6.2 Market Forecast
8.2.7 Others
8.2.7.1 Market Trends
8.2.7.2 Market Forecast
8.3 Europe
8.3.1 Germany
8.3.1.1 Market Trends
8.3.1.2 Market Forecast
8.3.2 France
8.3.2.1 Market Trends
8.3.2.2 Market Forecast
8.3.3 United Kingdom
8.3.3.1 Market Trends
8.3.3.2 Market Forecast
8.3.4 Italy
8.3.4.1 Market Trends
8.3.4.2 Market Forecast
8.3.5 Spain
8.3.5.1 Market Trends
8.3.5.2 Market Forecast
8.3.6 Russia
8.3.6.1 Market Trends
8.3.6.2 Market Forecast
8.3.7 Others
8.3.7.1 Market Trends
8.3.7.2 Market Forecast
8.4 Latin America
8.4.1 Brazil
8.4.1.1 Market Trends
8.4.1.2 Market Forecast
8.4.2 Mexico
8.4.2.1 Market Trends
8.4.2.2 Market Forecast
8.4.3 Others
8.4.3.1 Market Trends
8.4.3.2 Market Forecast
8.5 Middle East and Africa
8.5.1 Market Trends
8.5.2 Market Breakup by Country
8.5.3 Market Forecast
9 SWOT ANALYSIS
9.1 Overview
9.2 Strengths
9.3 Weaknesses
9.4 Opportunities
9.5 Threats
10 VALUE CHAIN ANALYSIS
11 PORTERS FIVE FORCES ANALYSIS
11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes
12 PRICE ANALYSIS
13 COMPETITIVE LANDSCAPE
13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
13.3.1 Abbvie Inc.
13.3.1.1 Company Overview
13.3.1.2 Product Portfolio
13.3.1.3 Financials
13.3.1.4 SWOT Analysis
13.3.2 AstraZeneca PLC
13.3.2.1 Company Overview
13.3.2.2 Product Portfolio
13.3.2.3 Financials
13.3.2.4 SWOT Analysis
13.3.3 Biogen Inc.
13.3.3.1 Company Overview
13.3.3.2 Product Portfolio
13.3.3.3 Financials
13.3.3.4 SWOT Analysis
13.3.4 Daiichi Sankyo Company Limited
13.3.4.1 Company Overview
13.3.4.2 Product Portfolio
13.3.4.3 Financials
13.3.4.4 SWOT Analysis
13.3.5 Eisai Co. Ltd.
13.3.5.1 Company Overview
13.3.5.2 Product Portfolio
13.3.5.3 Financials
13.3.5.4 SWOT Analysis
13.3.6 Eli Lilly and Company
13.3.6.1 Company Overview
13.3.6.2 Product Portfolio
13.3.6.3 Financials
13.3.6.4 SWOT Analysis
13.3.7 H. Lundbeck A/S
13.3.7.1 Company Overview
13.3.7.2 Product Portfolio
13.3.7.3 Financials
13.3.7.4 SWOT Analysis
13.3.8 F. Hoffmann-La Roche AG
13.3.8.1 Company Overview
13.3.8.2 Product Portfolio
13.3.8.3 SWOT Analysis
13.3.9 Merck & Co. Inc.
13.3.9.1 Company Overview
13.3.9.2 Product Portfolio
13.3.9.3 Financials
13.3.9.4 SWOT Analysis
13.3.10 Novartis AG
13.3.10.1 Company Overview
13.3.10.2 Product Portfolio
13.3.10.3 Financials
13.3.10.4 SWOT Analysis
13.3.11 Ono Pharmaceutical Co. Ltd.
13.3.11.1 Company Overview
13.3.11.2 Product Portfolio
13.3.11.3 Financials
13.3.11.4 SWOT Analysis
13.3.12 Pfizer Inc.
13.3.12.1 Company Overview
13.3.12.2 Product Portfolio
13.3.12.3 Financials
13.3.12.4 SWOT Analysis
13.3.13 Teva Pharmaceutical Industries Limited
13.3.13.1 Company Overview
13.3.13.2 Product Portfolio
13.3.13.3 Financials
13.3.13.4 SWOT Analysis
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL ALZHEIMER’S DRUGS MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY DRUG CLASS
6.1 Donepezil
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Galantamine
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Rivastigmine
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Memantine
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Others
6.5.1 Market Trends
6.5.2 Market Forecast
7 MARKET BREAKUP BY DISTRIBUTION CHANNEL
7.1 Hospital Pharmacy
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Retail Pharmacy
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Online Stores
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast
8 MARKET BREAKUP BY REGION
8.1 North America
8.1.1 United States
8.1.1.1 Market Trends
8.1.1.2 Market Forecast
8.1.2 Canada
8.1.2.1 Market Trends
8.1.2.2 Market Forecast
8.2 Asia Pacific
8.2.1 China
8.2.1.1 Market Trends
8.2.1.2 Market Forecast
8.2.2 Japan
8.2.2.1 Market Trends
8.2.2.2 Market Forecast
8.2.3 India
8.2.3.1 Market Trends
8.2.3.2 Market Forecast
8.2.4 South Korea
8.2.4.1 Market Trends
8.2.4.2 Market Forecast
8.2.5 Australia
8.2.5.1 Market Trends
8.2.5.2 Market Forecast
8.2.6 Indonesia
8.2.6.1 Market Trends
8.2.6.2 Market Forecast
8.2.7 Others
8.2.7.1 Market Trends
8.2.7.2 Market Forecast
8.3 Europe
8.3.1 Germany
8.3.1.1 Market Trends
8.3.1.2 Market Forecast
8.3.2 France
8.3.2.1 Market Trends
8.3.2.2 Market Forecast
8.3.3 United Kingdom
8.3.3.1 Market Trends
8.3.3.2 Market Forecast
8.3.4 Italy
8.3.4.1 Market Trends
8.3.4.2 Market Forecast
8.3.5 Spain
8.3.5.1 Market Trends
8.3.5.2 Market Forecast
8.3.6 Russia
8.3.6.1 Market Trends
8.3.6.2 Market Forecast
8.3.7 Others
8.3.7.1 Market Trends
8.3.7.2 Market Forecast
8.4 Latin America
8.4.1 Brazil
8.4.1.1 Market Trends
8.4.1.2 Market Forecast
8.4.2 Mexico
8.4.2.1 Market Trends
8.4.2.2 Market Forecast
8.4.3 Others
8.4.3.1 Market Trends
8.4.3.2 Market Forecast
8.5 Middle East and Africa
8.5.1 Market Trends
8.5.2 Market Breakup by Country
8.5.3 Market Forecast
9 SWOT ANALYSIS
9.1 Overview
9.2 Strengths
9.3 Weaknesses
9.4 Opportunities
9.5 Threats
10 VALUE CHAIN ANALYSIS
11 PORTERS FIVE FORCES ANALYSIS
11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes
12 PRICE ANALYSIS
13 COMPETITIVE LANDSCAPE
13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
13.3.1 Abbvie Inc.
13.3.1.1 Company Overview
13.3.1.2 Product Portfolio
13.3.1.3 Financials
13.3.1.4 SWOT Analysis
13.3.2 AstraZeneca PLC
13.3.2.1 Company Overview
13.3.2.2 Product Portfolio
13.3.2.3 Financials
13.3.2.4 SWOT Analysis
13.3.3 Biogen Inc.
13.3.3.1 Company Overview
13.3.3.2 Product Portfolio
13.3.3.3 Financials
13.3.3.4 SWOT Analysis
13.3.4 Daiichi Sankyo Company Limited
13.3.4.1 Company Overview
13.3.4.2 Product Portfolio
13.3.4.3 Financials
13.3.4.4 SWOT Analysis
13.3.5 Eisai Co. Ltd.
13.3.5.1 Company Overview
13.3.5.2 Product Portfolio
13.3.5.3 Financials
13.3.5.4 SWOT Analysis
13.3.6 Eli Lilly and Company
13.3.6.1 Company Overview
13.3.6.2 Product Portfolio
13.3.6.3 Financials
13.3.6.4 SWOT Analysis
13.3.7 H. Lundbeck A/S
13.3.7.1 Company Overview
13.3.7.2 Product Portfolio
13.3.7.3 Financials
13.3.7.4 SWOT Analysis
13.3.8 F. Hoffmann-La Roche AG
13.3.8.1 Company Overview
13.3.8.2 Product Portfolio
13.3.8.3 SWOT Analysis
13.3.9 Merck & Co. Inc.
13.3.9.1 Company Overview
13.3.9.2 Product Portfolio
13.3.9.3 Financials
13.3.9.4 SWOT Analysis
13.3.10 Novartis AG
13.3.10.1 Company Overview
13.3.10.2 Product Portfolio
13.3.10.3 Financials
13.3.10.4 SWOT Analysis
13.3.11 Ono Pharmaceutical Co. Ltd.
13.3.11.1 Company Overview
13.3.11.2 Product Portfolio
13.3.11.3 Financials
13.3.11.4 SWOT Analysis
13.3.12 Pfizer Inc.
13.3.12.1 Company Overview
13.3.12.2 Product Portfolio
13.3.12.3 Financials
13.3.12.4 SWOT Analysis
13.3.13 Teva Pharmaceutical Industries Limited
13.3.13.1 Company Overview
13.3.13.2 Product Portfolio
13.3.13.3 Financials
13.3.13.4 SWOT Analysis
LIST OF TABLES
Table 1: Global: Alzheimer’s Drugs Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Alzheimer’s Drugs Market Forecast: Breakup by Drug Class (in Million US$), 2023-2028
Table 3: Global: Alzheimer’s Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
Table 4: Global: Alzheimer’s Drugs Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 5: Global: Alzheimer’s Drugs Market: Competitive Structure
Table 6: Global: Alzheimer’s Drugs Market: Key Players
Table 1: Global: Alzheimer’s Drugs Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Alzheimer’s Drugs Market Forecast: Breakup by Drug Class (in Million US$), 2023-2028
Table 3: Global: Alzheimer’s Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
Table 4: Global: Alzheimer’s Drugs Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 5: Global: Alzheimer’s Drugs Market: Competitive Structure
Table 6: Global: Alzheimer’s Drugs Market: Key Players
LIST OF FIGURES
Figure 1: Global: Alzheimer’s Drugs Market: Major Drivers and Challenges
Figure 2: Global: Alzheimer’s Drugs Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Alzheimer’s Drugs Market: Breakup by Drug Class (in %), 2022
Figure 4: Global: Alzheimer’s Drugs Market: Breakup by Distribution Channel (in %), 2022
Figure 5: Global: Alzheimer’s Drugs Market: Breakup by Region (in %), 2022
Figure 6: Global: Alzheimer’s Drugs Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 7: Global: Alzheimer’s Drugs (Donepezil) Market: Sales Value (in Million US$), 2017 & 2022
Figure 8: Global: Alzheimer’s Drugs (Donepezil) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 9: Global: Alzheimer’s Drugs (Galantamine) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Alzheimer’s Drugs (Galantamine) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Alzheimer’s Drugs (Rivastigmine) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Alzheimer’s Drugs (Rivastigmine) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Alzheimer’s Drugs (Memantine) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Alzheimer’s Drugs (Memantine) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Alzheimer’s Drugs (Other Drug Classes) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Alzheimer’s Drugs (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Alzheimer’s Drugs (Hospital Pharmacy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Alzheimer’s Drugs (Hospital Pharmacy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Alzheimer’s Drugs (Retail Pharmacy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Alzheimer’s Drugs (Retail Pharmacy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Alzheimer’s Drugs (Online Stores) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Alzheimer’s Drugs (Online Stores) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Alzheimer’s Drugs (Other Distribution Channels) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Alzheimer’s Drugs (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: North America: Alzheimer’s Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: North America: Alzheimer’s Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: United States: Alzheimer’s Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: United States: Alzheimer’s Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Canada: Alzheimer’s Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Canada: Alzheimer’s Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: Asia Pacific: Alzheimer’s Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Asia Pacific: Alzheimer’s Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: China: Alzheimer’s Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: China: Alzheimer’s Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: Japan: Alzheimer’s Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: Japan: Alzheimer’s Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: India: Alzheimer’s Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: India: Alzheimer’s Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: South Korea: Alzheimer’s Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: South Korea: Alzheimer’s Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: Australia: Alzheimer’s Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: Australia: Alzheimer’s Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: Indonesia: Alzheimer’s Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: Indonesia: Alzheimer’s Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: Others: Alzheimer’s Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: Others: Alzheimer’s Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: Europe: Alzheimer’s Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: Europe: Alzheimer’s Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: Germany: Alzheimer’s Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: Germany: Alzheimer’s Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: France: Alzheimer’s Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: France: Alzheimer’s Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: United Kingdom: Alzheimer’s Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: United Kingdom: Alzheimer’s Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: Italy: Alzheimer’s Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: Italy: Alzheimer’s Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: Spain: Alzheimer’s Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: Spain: Alzheimer’s Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: Russia: Alzheimer’s Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: Russia: Alzheimer’s Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: Others: Alzheimer’s Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: Others: Alzheimer’s Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: Latin America: Alzheimer’s Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: Latin America: Alzheimer’s Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: Brazil: Alzheimer’s Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: Brazil: Alzheimer’s Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: Mexico: Alzheimer’s Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: Mexico: Alzheimer’s Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: Others: Alzheimer’s Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: Others: Alzheimer’s Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: Middle East and Africa: Alzheimer’s Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: Middle East and Africa: Alzheimer’s Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: Global: Alzheimer’s Drugs Industry: SWOT Analysis
Figure 74: Global: Alzheimer’s Drugs Industry: Value Chain Analysis
Figure 75: Global: Alzheimer’s Drugs Industry: Porter’s Five Forces Analysis
Figure 1: Global: Alzheimer’s Drugs Market: Major Drivers and Challenges
Figure 2: Global: Alzheimer’s Drugs Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Alzheimer’s Drugs Market: Breakup by Drug Class (in %), 2022
Figure 4: Global: Alzheimer’s Drugs Market: Breakup by Distribution Channel (in %), 2022
Figure 5: Global: Alzheimer’s Drugs Market: Breakup by Region (in %), 2022
Figure 6: Global: Alzheimer’s Drugs Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 7: Global: Alzheimer’s Drugs (Donepezil) Market: Sales Value (in Million US$), 2017 & 2022
Figure 8: Global: Alzheimer’s Drugs (Donepezil) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 9: Global: Alzheimer’s Drugs (Galantamine) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Alzheimer’s Drugs (Galantamine) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Alzheimer’s Drugs (Rivastigmine) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Alzheimer’s Drugs (Rivastigmine) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Alzheimer’s Drugs (Memantine) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Alzheimer’s Drugs (Memantine) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Alzheimer’s Drugs (Other Drug Classes) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Alzheimer’s Drugs (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Alzheimer’s Drugs (Hospital Pharmacy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Alzheimer’s Drugs (Hospital Pharmacy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Alzheimer’s Drugs (Retail Pharmacy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Alzheimer’s Drugs (Retail Pharmacy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Alzheimer’s Drugs (Online Stores) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Alzheimer’s Drugs (Online Stores) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Alzheimer’s Drugs (Other Distribution Channels) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Alzheimer’s Drugs (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: North America: Alzheimer’s Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: North America: Alzheimer’s Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: United States: Alzheimer’s Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: United States: Alzheimer’s Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Canada: Alzheimer’s Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Canada: Alzheimer’s Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: Asia Pacific: Alzheimer’s Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Asia Pacific: Alzheimer’s Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: China: Alzheimer’s Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: China: Alzheimer’s Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: Japan: Alzheimer’s Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: Japan: Alzheimer’s Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: India: Alzheimer’s Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: India: Alzheimer’s Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: South Korea: Alzheimer’s Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: South Korea: Alzheimer’s Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: Australia: Alzheimer’s Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: Australia: Alzheimer’s Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: Indonesia: Alzheimer’s Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: Indonesia: Alzheimer’s Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: Others: Alzheimer’s Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: Others: Alzheimer’s Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: Europe: Alzheimer’s Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: Europe: Alzheimer’s Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: Germany: Alzheimer’s Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: Germany: Alzheimer’s Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: France: Alzheimer’s Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: France: Alzheimer’s Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: United Kingdom: Alzheimer’s Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: United Kingdom: Alzheimer’s Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: Italy: Alzheimer’s Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: Italy: Alzheimer’s Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: Spain: Alzheimer’s Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: Spain: Alzheimer’s Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: Russia: Alzheimer’s Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: Russia: Alzheimer’s Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: Others: Alzheimer’s Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: Others: Alzheimer’s Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: Latin America: Alzheimer’s Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: Latin America: Alzheimer’s Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: Brazil: Alzheimer’s Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: Brazil: Alzheimer’s Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: Mexico: Alzheimer’s Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: Mexico: Alzheimer’s Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: Others: Alzheimer’s Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: Others: Alzheimer’s Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: Middle East and Africa: Alzheimer’s Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: Middle East and Africa: Alzheimer’s Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: Global: Alzheimer’s Drugs Industry: SWOT Analysis
Figure 74: Global: Alzheimer’s Drugs Industry: Value Chain Analysis
Figure 75: Global: Alzheimer’s Drugs Industry: Porter’s Five Forces Analysis
